In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
										Pharmaceutical companies submit a Prandase, Precose, Glucobay, Bay-g 5421, Acarbose Drug Master File in Korea (Prandase, Precose, Glucobay, Bay-g 5421, Acarbose KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prandase, Precose, Glucobay, Bay-g 5421, Acarbose. The MFDS reviews the Prandase, Precose, Glucobay, Bay-g 5421, Acarbose KDMF as part of the drug registration process and uses the information provided in the Prandase, Precose, Glucobay, Bay-g 5421, Acarbose KDMF to evaluate the safety and efficacy of the drug.
										After submitting a Prandase, Precose, Glucobay, Bay-g 5421, Acarbose KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prandase, Precose, Glucobay, Bay-g 5421, Acarbose API can apply through the Korea Drug Master File (KDMF).
										click here to find a list of Prandase, Precose, Glucobay, Bay-g 5421, Acarbose suppliers with KDMF on PharmaCompass.